S. Korea Takes Steps To Ensure Transparency Of Tamiflu Gift To North
This article was originally published in PharmAsia News
South Korea says it will take steps to be sure the doses of Roche's Tamiflu (oseltamivir) it is donating to North Korea actually get to their intended H1N1 flu targets
You may also be interested in...
Pfizer’s abrocitinib and Biogen/Eisai’s aducanumab are among a host of new investigational products that are under review by the European Medicines Agency.
The UK's Celleron has attracted a "blue chip suite of investors" to an Irish-domiciled spin-off based on the potential of Roche-developed emactuzumab for TGCT, a debilitating orphan disease that causes joint damage and has limited clinical options.
Topline results with AZD1222 have shown a lower efficacy rate than the Pfizer and Moderna vaccines, but a subgroup receiving a half-dose in their first injection showed a 90% efficacy result.